Parkman Healthcare Partners »

Intra Cellular Therapies shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $20M 243k 83.52
2024-09-30 $18M 242k 73.17
2024-06-30 $13M 185k 68.49
2024-03-31 $4.8M 70k 69.20

More positions owned by Parkman Healthcare Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Insulet Corporation (PODD)
CVS Caremark Corporation (CVS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Miragen Therapeutics (VRDN)
Zimmer Holdings (ZBH)
Stryker Corporation (SYK)
Qiagen Nv Com Shs (QGEN)
McKesson Corporation (MCK)
Danaher Corporation (DHR)
Kalvista Pharmaceuticals (KALV)
Uniqure Nv SHS (QURE)
Neurocrine Biosciences (NBIX)

View all positions for Parkman Healthcare Partners

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies